These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25919147)

  • 61. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
    Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
    Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autophagic responses to hypoxia and anticancer therapy in head and neck cancer.
    Wu H; Huang S; Zhang D
    Pathol Res Pract; 2015 Feb; 211(2):101-8. PubMed ID: 25523227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
    Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
    Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.
    Toustrup K; Sørensen BS; Lassen P; Wiuf C; Alsner J; Overgaard J;
    Radiother Oncol; 2012 Jan; 102(1):122-9. PubMed ID: 21996521
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.
    Kadletz L; Heiduschka G; Wiebringhaus R; Gurnhofer E; Kotowski U; Haymerle G; Brunner M; Barry C; Kenner L
    Cell Oncol (Dordr); 2017 Apr; 40(2):193-198. PubMed ID: 28039609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
    Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL
    Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Roles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancer.
    Gammon L; Mackenzie IC
    J Oral Pathol Med; 2016 Feb; 45(2):77-82. PubMed ID: 25952002
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
    Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
    Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer].
    Sadick M; Schoenberg SO; Hoermann K; Sadick H
    Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S27-47. PubMed ID: 22456918
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.
    Ausoni S; Boscolo-Rizzo P; Singh B; Da Mosto MC; Spinato G; Tirelli G; Spinato R; Azzarello G
    Cancer Metastasis Rev; 2016 Sep; 35(3):413-26. PubMed ID: 27194534
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation.
    Thomas Koch D; Pickhard A; Gebel L; Buchberger AMS; Bas M; Mogler C; Reiter R; Piontek G; Wirth M
    Oncotarget; 2017 May; 8(20):32668-32682. PubMed ID: 28427242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mucin 1 regulates the hypoxia response in head and neck cancer cells.
    Utispan K; Koontongkaew S
    J Pharmacol Sci; 2021 Dec; 147(4):331-339. PubMed ID: 34663515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck.
    Kunder S; Chatterjee A; Manna S; Mahimkar M; Patil A; Rangarajan V; Budrukkar A; Ghosh-Laskar S; Agarwal JP; Gupta T
    World J Nucl Med; 2021; 20(3):228-236. PubMed ID: 34703390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunosuppression Impact on Head and Neck Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-analysis.
    Elghouche AN; Pflum ZE; Schmalbach CE
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):439-446. PubMed ID: 30348055
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.
    Keulers TG; Koch A; van Gisbergen MW; Barbeau LMO; Zonneveld MI; de Jong MC; Savelkouls KGM; Wanders RG; Bussink J; Melotte V; Rouschop KMA
    Autophagy; 2022 Aug; 18(8):1898-1914. PubMed ID: 34904929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.